Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:IBMNASDAQ:NVDANYSE:RHOTCMKTS:RHHBYOTCMKTS:RHHVFNASDAQ:RXRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBMInternational Business Machines$243.83-1.0%$249.51$162.62▼$266.45$226.25B0.744.09 million shs3.13 million shsNVDANVIDIA$109.67-1.6%$125.01$75.61▼$195.95$2.68T1.77314.71 million shs229.05 million shsRHRH$236.26-2.9%$335.63$212.04▼$457.26$4.40B2.5750,095 shs850,894 shsRHHBYRoche$41.92-1.0%$41.17$29.20▼$44.31$267.36B0.413.28 million shs5.20 million shsRHHVFRoche$339.65+2.5%$328.47$233.12▼$354.19N/AN/A4,441 shs527 shsRXRXRecursion Pharmaceuticals$5.81-2.7%$7.44$5.60▼$12.36$2.34B0.8510.75 million shs15.13 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBMInternational Business Machines0.00%+0.03%-3.71%+9.45%+27.79%NVDANVIDIA0.00%-6.82%-8.72%-19.95%+21.52%RHRH0.00%-2.47%-27.88%-40.65%-20.48%RHHBYRoche0.00%-4.07%+1.16%+19.53%+33.89%RHHVFRoche0.00%-2.76%+2.55%+20.93%+34.57%RXRXRecursion Pharmaceuticals0.00%-13.02%-24.25%-21.38%-42.87%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIBMInternational Business Machines4.2951 of 5 stars2.22.03.33.53.41.71.9NVDANVIDIA4.8819 of 5 stars4.53.01.73.03.32.51.9RHRH4.7398 of 5 stars4.34.00.01.42.24.21.9RHHBYRocheN/AN/AN/AN/AN/AN/AN/AN/ARHHVFRoche0.0742 of 5 stars0.01.01.70.00.60.00.0RXRXRecursion Pharmaceuticals2.1711 of 5 stars3.22.00.00.02.22.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIBMInternational Business Machines 2.41Hold$231.44-5.08% DownsideNVDANVIDIA 2.98Moderate Buy$171.5156.39% UpsideRHRH 2.59Moderate Buy$403.2570.68% UpsideRHHBYRoche 2.50Moderate BuyN/AN/ARHHVFRoche 0.00N/AN/AN/ARXRXRecursion Pharmaceuticals 2.40Hold$8.2542.00% UpsideCurrent Analyst Ratings BreakdownLatest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/26/2025RHRHBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$510.00 ➝ $410.003/26/2025RHRHWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$500.00 ➝ $350.003/26/2025RHRHGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$550.00 ➝ $500.003/24/2025RHRHCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$556.00 ➝ $437.003/24/2025RHRHTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$500.00 ➝ $420.003/21/2025RHRHUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$440.00 ➝ $250.003/20/2025NVDANVIDIADA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$135.00 ➝ $125.003/20/2025NVDANVIDIAWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform3/19/2025NVDANVIDIAKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$190.003/19/2025NVDANVIDIAMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$162.003/19/2025NVDANVIDIAStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$180.00(Data available from 3/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIBMInternational Business Machines$62.75B3.60$14.29 per share17.06$29.62 per share8.23NVDANVIDIA$130.50B20.51$0.97 per share112.93$1.72 per share63.76RHRH$3.11B1.41$12.39 per share19.07($16.16) per share-14.62RHHBYRoche$68.73B3.89$3.27 per share12.82$5.81 per share7.22RHHVFRocheN/AN/AN/AN/AN/AN/ARXRXRecursion Pharmaceuticals$58.49M39.93N/AN/A$1.98 per share2.93Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIBMInternational Business Machines$6.02B$6.4138.0421.025.819.60%38.99%7.14%4/23/2025 (Estimated)NVDANVIDIA$29.76B$2.9443.1627.561.7655.69%114.83%76.61%5/28/2025 (Estimated)RHRH$127.56M$3.4867.8917.132.652.25%-35.72%2.09%4/2/2025 (Estimated)RHHBYRoche$9.40BN/A0.0013.972.18N/AN/AN/AN/ARHHVFRocheN/A$10.8131.42∞N/AN/AN/AN/AN/ARXRXRecursion Pharmaceuticals-$328.07M-$1.66N/AN/AN/A-579.52%-76.56%-55.68%5/8/2025 (Estimated)Latest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/23/2025N/AIBMInternational Business Machines$1.43N/AN/AN/A$14.41 billionN/A4/2/2025N/ARHRH$1.90N/AN/AN/A$828.21 millionN/A2/28/2025Q4 2024RXRXRecursion Pharmaceuticals-$0.36-$0.53-$0.17-$0.53$19.04 million$4.60 million2/26/2025Q4 2025NVDANVIDIA$0.84$0.89+$0.05$0.89$38.16 billion$39.33 billion1/29/2025Q4 2024IBMInternational Business Machines$3.77$3.92+$0.15$3.10$17.60 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIBMInternational Business Machines$6.682.74%+0.61%104.21%29 YearsNVDANVIDIA$0.040.04%+33.42%1.36%N/ARHRHN/AN/AN/AN/AN/ARHHBYRoche$0.852.03%N/AN/AN/ARHHVFRoche$7.802.30%N/A72.16%N/ARXRXRecursion PharmaceuticalsN/AN/AN/AN/AN/ALatest RXRX, IBM, RH, RHHBY, RHHVF, and NVDA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/26/2025NVDANVIDIAquarterly$0.010.03%3/12/20253/12/20254/2/20253/21/2025RHHVFRoche$9.703.17%3/27/20253/28/20253/31/20251/28/2025IBMInternational Business MachinesQuarterly$1.672.92%2/10/20252/10/20253/10/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIBMInternational Business Machines1.821.041.00NVDANVIDIA0.134.103.64RHRHN/A1.430.33RHHBYRoche0.861.260.97RHHVFRocheN/AN/AN/ARXRXRecursion Pharmaceuticals0.044.354.35Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIBMInternational Business Machines58.96%NVDANVIDIA65.27%RHRH90.17%RHHBYRocheN/ARHHVFRoche29.01%RXRXRecursion Pharmaceuticals89.06%Insider OwnershipCompanyInsider OwnershipIBMInternational Business Machines0.18%NVDANVIDIA4.23%RHRH28.10%RHHBYRocheN/ARHHVFRocheN/ARXRXRecursion Pharmaceuticals15.75%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIBMInternational Business Machines311,300927.26 million924.00 millionOptionableNVDANVIDIA29,60024.40 billion23.45 billionOptionableRHRH6,50018.60 million13.38 millionOptionableRHHBYRoche103,6056.38 billionN/ANot OptionableRHHVFRoche103,605N/AN/ANot OptionableRXRXRecursion Pharmaceuticals400401.99 million329.18 millionOptionableRXRX, IBM, RH, RHHBY, RHHVF, and NVDA HeadlinesRecent News About These CompaniesNvidia Has 81% of Its $304 Million Stock Portfolio Invested in 3 Groundbreaking AI StocksMarch 30 at 4:30 AM | fool.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Acquired by IQ EQ FUND MANAGEMENT IRELAND LtdMarch 29 at 5:47 AM | marketbeat.comHighTower Advisors LLC Acquires 98,626 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)March 28 at 3:22 AM | marketbeat.comRecursion: A Look At Near-Term Phase 1b And Phase 2 CatalystsMarch 27 at 11:30 AM | seekingalpha.comSwiss National Bank Grows Stock Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)March 27 at 3:29 AM | marketbeat.comIs Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit?March 26, 2025 | msn.comWhy Recursion Pharmaceuticals Inc. (RXRX) Performed Worst On Tuesday?March 26, 2025 | msn.comCathie Wood’s ARK Investment buys 205K shares of Recursion Pharmaceuticals todayMarch 26, 2025 | markets.businessinsider.comCathie Wood’s ARK Investment buys 161K shares of Recursion Pharmaceuticals todayMarch 21, 2025 | markets.businessinsider.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Purchased by Charles Schwab Investment Management Inc.March 21, 2025 | marketbeat.comWhy Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market TodayMarch 20, 2025 | zacks.comPrivium Fund Management B.V. Purchases 41,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)March 20, 2025 | marketbeat.comPlatinum Investment Management Ltd. Acquires 546,929 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)March 20, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down - Here's WhyMarch 19, 2025 | marketbeat.comRecursion appoints Namandje Bumpus, Elaine Sun to boardMarch 18, 2025 | markets.businessinsider.comRecursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity OfferingMarch 18, 2025 | finance.yahoo.comRecursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Up 4.5% - What's Next?March 18, 2025 | marketbeat.comWhy Recursion Pharmaceuticals (RXRX) Went Up on Monday?March 18, 2025 | insidermonkey.comRecursion Pharma Down 37% in a Month: Buy, Sell or Hold the Stock?March 18, 2025 | zacks.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Sold by Nikko Asset Management Americas Inc.March 18, 2025 | marketbeat.comWhich Is a Better Investment, Recursion Pharmaceuticals, Inc. or Zai Lab Limited Stock?March 17, 2025 | aaii.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesNVIDIA Stock Remains Stunningly Undervalued—Here’s WhyBy Thomas Hughes | March 11, 2025View NVIDIA Stock Remains Stunningly Undervalued—Here’s WhyThese 3 Iconic Brands Just Announced Bigger Dividend PayoutsBy Leo Miller | March 7, 2025View These 3 Iconic Brands Just Announced Bigger Dividend PayoutsOne Must-Buy Stock and One to Avoid as Tariffs Shake the MarketBy Gabriel Osorio-Mazilli | March 9, 2025View One Must-Buy Stock and One to Avoid as Tariffs Shake the MarketTariffs Won’t Stop These 3 Stocks From RisingBy Chris Markoch | March 5, 2025View Tariffs Won’t Stop These 3 Stocks From RisingOracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term BuyBy Thomas Hughes | March 11, 2025View Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term BuyRXRX, IBM, RH, RHHBY, RHHVF, and NVDA Company DescriptionsInternational Business Machines NYSE:IBM$243.83 -2.38 (-0.97%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$243.03 -0.80 (-0.33%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.NVIDIA NASDAQ:NVDA$109.67 -1.76 (-1.58%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$109.02 -0.65 (-0.59%) As of 03/28/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.RH NYSE:RH$236.26 -7.17 (-2.94%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$232.71 -3.54 (-1.50%) As of 03/28/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RH, together with its subsidiaries, operates as a retailer in the home furnishings market. The company offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, baby, child, and teen furnishings. It provides its products through rh.com, rhbabyandchild.com, rhteen.com, rhmodern.com, and waterworks.com online channels, as well as operates RH Galleries, RH outlet stores, RH Guesthouse, and Waterworks showrooms in the United States, Canada, the United Kingdom, and Germany. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.Roche OTCMKTS:RHHBY$41.92 -0.43 (-1.02%) As of 03/28/2025 04:00 PM EasternRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Roche OTCMKTS:RHHVF$339.65 +8.22 (+2.48%) As of 03/28/2025 03:15 PM EasternRoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Recursion Pharmaceuticals NASDAQ:RXRX$5.81 -0.16 (-2.68%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$5.78 -0.03 (-0.60%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/24 - 03/28 JPMorgan: The 'NVIDIA of Banking' Poised for More Gains? Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback Joby Aviation Stock: Analyst Confidence and Smart Money Align Ibotta Stock: Why the Buyback Looks Like a Bullish Bet Archer Aviation Stock Sees Surge in Institutional Buys How Can Tomahawk 6 Contribute to Broadcom's AI Growth Story? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
